Monogram Technologies acquired by ZIMMER BIOMET

Zimmer Biomet acquires Monogram Technologies, an AI-driven orthopedic robotics company, to strengthen its leadership position in the fast-growing orthopedic surgical robotics segment. The transaction, closed in October 2025, integrates Monogram's semi-autonomous and fully autonomous technologies into Zimmer Biomet's existing portfolio. The strategic logic rests on several drivers. First, Monogram's CT-based technology complements Zimmer Biomet's ROSA platform, which uses an imageless approach, enabling the group to address diverse surgeon preferences in surgical techniques (with or without CT, robotic or non-robotic, manual or autonomous). Second, the acquisition positions Zimmer Biomet as the first and only player in orthopedics to offer a complete range from simplified navigation to fully autonomous robotics. This transaction aims to improve adoption of Zimmer Biomet's robotic knee solutions in the United States, a segment where the group seeks to regain market share. Monogram's integration also enables expansion of the customer base reached through a broader product offering and strengthens the group's global knee portfolio. The payment structure includes a cash upfront and CVRs (contingent value rights) tied to achievement of product development, regulatory, and revenue milestones through 2030, aligning Monogram shareholders' interests with long-term commercial success.